Southport Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-739
| Closed | -$493K | – | 325 |
|
|
2021
Q4 | $493K | Sell |
739
-8
| -1% | -$5K | 0.09% | 201 |
|
|
2021
Q3 | $427K | Sell |
747
-3,511
| -82% | -$1.93M | 0.17% | 148 |
|
|
2021
Q2 | $2.15M | Sell |
4,258
-38
| -0.9% | -$17.9K | 0.53% | 52 |
|
|
2021
Q1 | $1.96M | Buy |
4,296
+27
| +0.6% | +$12.9K | 0.52% | 56 |
|
|
2020
Q4 | $1.99M | Sell |
4,269
-86
| -2% | -$40.3K | 0.71% | 36 |
|
|
2020
Q3 | $1.92M | Buy |
4,355
+88
| +2% | +$36.4K | 0.74% | 34 |
|
|
2020
Q2 | $1.55M | Buy |
4,267
+9
| +0.2% | +$3.02K | 0.66% | 46 |
|
|
2020
Q1 | $1.21M | Sell |
4,258
-141
| -3% | -$44.5K | 0.64% | 53 |
|
|
2019
Q4 | $1.43M | Sell |
4,399
-109
| -2% | -$33.1K | 0.56% | 59 |
|
|
2019
Q3 | $1.31M | Buy |
4,508
+136
| +3% | +$38.9K | 0.59% | 48 |
|
|
2019
Q2 | $1.28M | Sell |
4,372
-10
| -0.2% | -$2.75K | 0.58% | 55 |
|
|
2019
Q1 | $1.2M | Sell |
4,382
-121
| -3% | -$30.1K | 0.53% | 64 |
|
|
2018
Q4 | $1.01M | Buy |
4,503
+53
| +1% | +$12.4K | 0.51% | 65 |
|
|
2018
Q3 | $1.09M | Buy |
4,450
+25
| +0.6% | +$5.75K | 0.46% | 63 |
|
|
2018
Q2 | $917K | Sell |
4,425
-85
| -2% | -$18K | 0.41% | 70 |
|
|
2018
Q1 | $931K | Sell |
4,510
-140
| -3% | -$29.4K | 0.42% | 80 |
|
|
2017
Q4 | $883K | Sell |
4,650
-1,400
| -23% | -$268K | 0.34% | 85 |
|
|
2017
Q3 | $1.15M | Hold |
6,050
| – | – | 0.49% | 74 |
|
|
2017
Q2 | $1.06M | Hold |
6,050
| – | – | 0.46% | 77 |
|
|
2017
Q1 | $929K | Hold |
6,050
| – | – | 0.52% | 67 |
|
|
2016
Q4 | $854K | Hold |
6,050
| – | – | 0.52% | 67 |
|
|
2016
Q3 | $962K | Hold |
6,050
| – | – | 0.67% | 49 |
|
|
2016
Q2 | $894K | Hold |
6,050
| – | – | 0.5% | 61 |
|
|
2016
Q1 | $857K | Hold |
6,050
| – | – | 0.55% | 61 |
|
|
2015
Q4 | $858K | Buy |
6,050
+115
| +2% | +$15.3K | 0.55% | 63 |
|
|
2015
Q3 | $726K | Hold |
5,935
| – | – | 0.49% | 69 |
|
|
2015
Q2 | $770K | Sell |
5,935
-1,400
| -19% | -$183K | 0.46% | 70 |
|
|
2015
Q1 | $985K | Hold |
7,335
| – | – | 0.58% | 57 |
|
|
2014
Q4 | $919K | Hold |
7,335
| – | – | 0.55% | 59 |
|
|
2014
Q3 | $893K | Hold |
7,335
| – | – | 0.59% | 57 |
|
|
2014
Q2 | $866K | Hold |
7,335
| – | – | 0.58% | 54 |
|
|
2014
Q1 | $882K | Hold |
7,335
| – | – | 0.62% | 52 |
|
|
2013
Q4 | $817K | Hold |
7,335
| – | – | 0.58% | 57 |
|
|
2013
Q3 | $676K | Hold |
7,335
| – | – | 0.53% | 64 |
|
|
2013
Q2 | $621K | Buy |
+7,335
| New | +$611K | 0.51% | 61 |
|
Other funds holding TMO
Southport Capital Management's TMO Position: Q1 2022 in Review
Southport Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 739 shares — an estimated $493K sold.
Southport Capital Management first reported a position in TMO in Q2 2013 and held it in 35 quarters. The position peaked at $2.15M in Q2 2021. 2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.
- Southport Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
- Southport Capital Management sold 739 Thermo Fisher Scientific shares in Q1 2022, an estimated $493K.
- Southport Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 35 quarters.
- Southport Capital Management's Thermo Fisher Scientific position peaked at $2.15M in Q2 2021.
- 2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.
Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.